Company Filing History:
Years Active: 2024
Title: Jacopo Sgrignani: Innovator in Peptide Inhibitors
Introduction
Jacopo Sgrignani is a notable inventor based in Stezzano, Italy. He has made significant contributions to the field of biomedicine, particularly through his innovative work on peptide inhibitors. His research focuses on the interaction between HMGB1 and CXCL12, which has implications for treating inflammation and immune-related diseases.
Latest Patents
Sgrignani holds a patent for "Peptide inhibitors targeting the CXCL12/HMGB1 interaction and uses thereof." This invention provides novel peptides that bind to HMGB1 and inhibit its interaction with CXCL12. The patent also encompasses proteins, virus-like particles, nanoparticles, and compositions that include these peptides and nucleic acids encoding them. Furthermore, the methods for utilizing these peptides are outlined, emphasizing their potential in therapeutic applications.
Career Highlights
Jacopo Sgrignani is affiliated with the Institute for Research in Biomedicine, where he continues to advance his research. His work is characterized by a commitment to understanding complex biological interactions and developing innovative solutions for medical challenges.
Collaborations
Sgrignani collaborates with esteemed colleagues such as Andrea Cavalli and Mariagrazia Uguccioni. These partnerships enhance the scope and impact of his research, fostering a collaborative environment that drives innovation.
Conclusion
Jacopo Sgrignani's contributions to peptide inhibitors represent a significant advancement in biomedicine. His innovative work holds promise for the treatment of various diseases, showcasing the importance of research and collaboration in the field.